Progyny Inc. (PGNY) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Progyny Inc. (PGNY:NASDAQ), powered by AI.

Current Price
$26.63
P/E Ratio
39.0
Market Cap
2.3B
Sector
Healthcare
What is the Progyny Inc. stock price forecast?

Progyny Inc. is currently trading at $26.63. View real-time AI analysis on Alpha Lenz.

What is Progyny Inc. insider trading activity?

View the latest insider trading data for Progyny Inc. on Alpha Lenz.

What is Progyny Inc.'s P/E ratio?

Progyny Inc.'s P/E ratio is 39.0.

Progyny Inc.

NASDAQ · PGNY
$26.63+0.98(+3.82%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Progyny Inc.'s future dividend policy...
Alpha Chat Insight

Progyny Inc. trades at a P/E of 39.0 (premium valuation) with solid ROE of 12.5%. 3Y revenue CAGR of 17.9% highlights clear growth momentum.

Ask for details

Company Overview

Progyny Inc. is a leading fertility benefits management company that offers advanced and technology-driven solutions to enhance reproductive health benefits for employers and their employees. The company's primary function is to provide comprehensive fertility and family-building benefits, supporting services that include fertility preservation, ovulation induction, insemination, in vitro fertilization (IVF), donor and gestational carrier services. Progyny Inc. plays a pivotal role in the insurance and healthcare sectors, working closely with large employers to provide a managed, streamlined approach to fertility care covered under their benefit plans. By addressing a significant and growing demand for fertility treatments and support, Progyny helps employers optimize their healthcare budgets while enhancing employee satisfaction and outcomes. With its innovative approach to holistic fertility management, Progyny Inc. positions itself as a vital player in the evolving landscape of employee health benefits and represents an important intersection between healthcare delivery and corporate wellness initiatives.

CEOMr. Peter Anevski CPA
SectorHealthcare
IndustryHealthcare Plans
Employees675

Company Statistics

FY 2025

Profile

$2.28BMarket Cap
$1.29BRevenue
0.00Shares Out
675Employees

Margins

23.63%Gross
7.00%EBITDA
6.62%Operating
7.41%Pre-Tax
4.54%Net

Valuation

38.98P/E
4.42P/B
1.77EV/Sales
24.34EV/EBITDA
11.89P/FCF

Growth (CAGR)

17.87%Rev 3Yr
30.17%Rev 5Yr
54.02%Op Inc 3Yr
59.17%Op Inc 5Yr
24.45%Net Inc 3Yr
4.72%Net Inc 5Yr

Returns

8.67%ROA
12.48%ROE
12.64%ROIC

Financial Health

$112.24MCash & Cash Equivalents
$114.15MNet Debt
43.87%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Progyny Inc. (ticker: PGNY) is a company listed on NASDAQ in the Healthcare sector (Healthcare Plans). It has approximately 675 employees. Market cap is $2.3B.

The current price is $26.63 with a P/E ratio of 38.98x and P/B of 4.42x.

ROE is 12.48% and operating margin is 6.62%. Annual revenue is $1.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Progyny Inc. (PGNY) Stock Forecast 2026 $26.63 — Price, Financials & Analyst Targets | Alpha Lenz